Literature DB >> 27560278

Rhythm control in atrial fibrillation.

Jonathan P Piccini1, Laurent Fauchier2.   

Abstract

Many patients with atrial fibrillation have substantial symptoms despite ventricular rate control and require restoration of sinus rhythm to improve their quality of life. Acute restoration (ie, cardioversion) and maintenance of sinus rhythm in patients with atrial fibrillation are referred to as rhythm control. The decision to pursue rhythm control is based on symptoms, the type of atrial fibrillation (paroxysmal, persistent, or long-standing persistent), patient comorbidities, general health status, and anticoagulation status. Many patients have recurrent atrial fibrillation and require further intervention to maintain long term sinus rhythm. Antiarrhythmic drug therapy is generally recommended as a first-line therapy and drug selection is on the basis of the presence or absence of structural heart disease or heart failure, electrocardiographical variables, renal function, and other comorbidities. In patients who continue to have recurrent atrial fibrillation despite medical therapy, catheter ablation has been shown to substantially reduce recurrent atrial fibrillation, decrease symptoms, and improve quality of life, although recurrence is common despite continued advancement in ablation techniques.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27560278     DOI: 10.1016/S0140-6736(16)31277-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

Review 1.  Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis.

Authors:  Natale Daniele Brunetti; Nicola Tarantino; Luisa De Gennaro; Michele Correale; Francesco Santoro; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

2.  Non-vitamin K antagonist oral anticoagulants in cardioversion of atrial fibrillation: a network meta-analysis.

Authors:  Babikir Kheiri; Tarek Haykal; Ahmed Abdalla; Mohammed Osman; Sahar Ahmed; Khansa Osman; Ghassan Bachuwa; Mustafa Hassan; Deepak L Bhatt
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

3.  Ca2+/calmodulin-dependent kinase II-dependent regulation of atrial myocyte late Na+ current, Ca2+ cycling, and excitability: a mathematical modeling study.

Authors:  Birce Onal; Daniel Gratz; Thomas J Hund
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-25       Impact factor: 4.733

4.  Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019.

Authors:  Gilson Soares Feitosa-Filho; José Maria Peixoto; José Elias Soares Pinheiro; Abrahão Afiune Neto; Afonso Luiz Tavares de Albuquerque; Álvaro César Cattani; Amit Nussbacher; Ana Amelia Camarano; Angela Hermínia Sichinels; Antonio Carlos Sobral Sousa; Aristóteles Comte de Alencar Filho; Claudia F Gravina; Dario Celestino Sobral Filho; Eduardo Pitthan; Elisa Franco de Assis Costa; Elizabeth da Rosa Duarte; Elizabete Viana de Freitas; Emilio Hideyuki Moriguchi; Evandro Tinoco Mesquita; Fábio Fernandes; Gilson Soares Feitosa; Humberto Pierre; Ilnei Pereira Filho; Izo Helber; Jairo Lins Borges; Jéssica Myrian de Amorim Garcia; José Antonio Gordillo de Souza; José Carlos da Costa Zanon; Josmar de Castro Alves; Kalil Lays Mohallem; Laura Mariana de Siqueira Mendonça Chaves; Lídia Ana Zytynski Moura; Márcia Cristina Amélia da Silva; Maria Alice de Vilhena Toledo; Maria Elisa Lucena Sales de Melo Assunção; Mauricio Wajngarten; Mauro José Oliveira Gonçalves; Neuza Helena Moreira Lopes; Nezilour Lobato Rodrigues; Paulo Roberto Pereira Toscano; Pedro Rousseff; Ricardo Antonio Rosado Maia; Roberto Alexandre Franken; Roberto Dischinger Miranda; Roberto Gamarski; Ronaldo Fernandes Rosa; Silvio Carlos de Moraes Santos; Siulmara Cristina Galera; Stela Maris da Silva Grespan; Teresa Cristina Rogerio da Silva; William Antonio de Magalhães Esteves
Journal:  Arq Bras Cardiol       Date:  2019-06-06       Impact factor: 2.000

5.  Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study.

Authors:  Francesco Paciullo; Marco Proietti; Vanessa Bianconi; Alessandro Nobili; Matteo Pirro; Pier Mannuccio Mannucci; Gregory Y H Lip; Graziana Lupattelli
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

Review 6.  50-Year-Old Man With Dyspnea on Exertion, Orthopnea, and Weight Gain.

Authors:  Sae K Jang; Megha Prasad; LaPrincess C Brewer
Journal:  Mayo Clin Proc       Date:  2019-08       Impact factor: 7.616

7.  Region-specific parasympathetic nerve remodeling in the left atrium contributes to creation of a vulnerable substrate for atrial fibrillation.

Authors:  Georg Gussak; Anna Pfenniger; Lisa Wren; Mehul Gilani; Wenwei Zhang; Shin Yoo; David A Johnson; Amy Burrell; Brandon Benefield; Gabriel Knight; Bradley P Knight; Rod Passman; Jeffrey J Goldberger; Gary Aistrup; J Andrew Wasserstrom; Yohannes Shiferaw; Rishi Arora
Journal:  JCI Insight       Date:  2019-10-17

8.  Rabbit model to simulate the residual conduction gaps after radiofrequency ablation on the anterior wall of left atrial appendage.

Authors:  Huaner Ni; Ying Zhuge; Lin Li; Weifeng Li; Congcong Zhao; Yujie Wang; Fang Wang
Journal:  J Interv Card Electrophysiol       Date:  2018-04-10       Impact factor: 1.900

9.  Inhibition of Small-Conductance Ca2+-Activated K+ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation?

Authors:  Jordi Heijman; Dobromir Dobrev
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-10

Review 10.  Atrial Fibrillation Ablation in Patients with Heart Failure: One Size Does Not Fit All.

Authors:  Rahul K Mukherjee; Steven E Williams; Steven A Niederer; Mark D O'Neill
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.